Femovan

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1987-1994
012319871994

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
A cross-over study of two oral contraceptive formulations, containing 30 micrograms ethinylestradiol in combination with 150… (More)
Is this relevant?
1994
1994
31 women aged 26-35 were observed during hormonal contraception with Femovan (in Poland registered as Femoden). The aim of the… (More)
Is this relevant?
1992
1992
The serum concentrations of gestodene (CAS 60282-87-3) as well as the binding of this progestin to serum proteins were studied in… (More)
Is this relevant?
1992
1992
Two low-dose oral contraceptives, both containing the same dose of ethinyl estradiol (EE2, CAS 57-63-6) but different progestins… (More)
Is this relevant?
1990
1990
The low dose oral contraceptive Femovan/Gynera which contains 0.03 mg Ethinylestradiol and 0.075 mg Gestoden was examined in… (More)
Is this relevant?
1990
1990
Oral contraception has proved to be the most efficient reversible method of fertility control for over 25 years. During this… (More)
Is this relevant?
1990
1990
Results from two clinical pharmacokinetic studies are given. The first study was an observational study in oral contraceptive… (More)
Is this relevant?
1988
1988
  • Contraceptive technology update
  • 1988
A generation of progestins is being widely used in Europe, and experts predict these agents will eventually replace the… (More)
Is this relevant?
Review
1988
Review
1988
The pharmacology and the application in oral hormonal contraceptives of four new progestogens--gestodene, desogestrel… (More)
Is this relevant?
1987
1987
  • Ken Fotherby
  • Advances in contraception : the official journal…
  • 1987
 
Is this relevant?